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Introduction. Posttraumatic psychopathology (PTP) describes the spectrum of conditions that can complicate the recovery from
commonly occurring musculoskeletal trauma. There is a clear association with the activation of the hypothalamic-pituitary-
adrenal axis (HPAA), and we wished to examine the predictive value of proinﬂammatory markers of the HPAA and of the GABA,
which acts as an inhibitory regulator. Methods. Levels of proinﬂammatory markers and GABA were measured in 84 patients who
had suﬀered musculoskeletal injuries requiring hospitalisation. PTP was assessed by the use of the General Health Questionnaire
(GHQ) at presentation and again at two- and six-month reviews. Results. Signiﬁcant psychological disturbance was noted in 39%
of patients at two months and falling back to 18% by six months. There was no correlation between any of the markers tested at
presentationandPTPatfollow-up.Discussion.TheHPAAresponsetotraumaandthedevelopmentofPTPareextremelycomplex.
It is unlikely that a simple blood assay will provide signiﬁcant predictive information, while incident speciﬁc information and
patient perception are of more practical use.
Copyright © 2008 Alasdair George Sutherland et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
Psychological disturbance after traumatic injury is common,
and it is now well recognised that disorders such as
posttraumatic stress disorder (PTSD) are not conﬁned to
c o m b a tv e t e r a n so rt h es u r v i v o r so fm a j o rc i v i la c c i d e n t s
[1–3]. There is a spectrum of posttraumatic problems;
from short-lived adjustment conditions such as acute stress
disorder (ASD) to full PTSD, and a range of comorbidities
such as anxiety and depression can coexist with speciﬁc
posttraumatic symptoms. Rather than focusing upon only
the most severe extreme, we prefer to consider the full
spectrum of posttraumatic psychological (PTP) symptoms
to describe the range of problems that may occur after
at r a u m a t i ce v e n t[ 2]. We have previously demonstrated
that 2 months after a musculoskeletal injury up to 46% of
patients have demonstrable psychopathology, falling to 22%
by six months [4]. This PTP is important to the treating
trauma surgeon, as there is a clear relationship between psy-
chopathology and impaired functional recovery. Although
it is not clear that primary treatment of the psychological
problems will necessarily yield an improvement in recovery
from the physical aspects of the injury [5, 6], it is certainly
clear that holistic care of the injured patient must include
management of their psychological state. The ability to
predict which patients are at highest risk of PTP, including
PTSD, would allow scarce resources to be targeted at those
most in need.
Previous work from our and other units has charac-
terised aspects of the injury, including injury severity and
the patient’s experience of the accident, which are associated
with increased risk of PTP [4, 7–9]. The awareness of
the centrality of the hypothalamic-pituitary-adrenal axis
(HPAA) to the development of PTP [10]h a sl e dt oa
search for biological markers that might predict a tendency
to develop PTP that is independent of the injury itself.2 Mediators of Inﬂammation
A recent paper has suggested that low levels of γ-amino
butyric acid (GABA) [11], an inhibitory modulator of the
HPAA, may predict PTSD after road traﬃc accidents. The
proinﬂammatory cytokines interleukin-6 and its soluble
receptor (IL-6 and sIL-6r) and tumour necrosis factor-α
(TNF-α) have been identiﬁed as indicators of the inﬂam-
matory response to physical stress and HPA disruption [12–
17]. There is some contradictory evidence for elevation of
these cytokines in patients with established PTSD [18–20]
and posttraumatic psychopathology [21]. The relationship
between psychiatric illness and cytokine disturbance has
been more widely studied, particularly with regard to
schizophrenia [22, 23], but it remains to be seen how this
can be integrated in the understanding of changes in PTP.
GABA has an important inhibitory role in the function
of the HPAA [24], and low levels have been associated
with increased risk of development of acute PTSD [11,
25].
WewishedtostudytherelationshipbetweenGABAanda
range of proinﬂammatory markers, which also reﬂect HPAA
function, and the development of PTP in our centre.
2. MATERIALS AND METHODS
As part of a wider study of trauma outcomes, a cohort
of patients treated in the orthopaedic trauma unit of
Aberdeen Royal Inﬁrmary were approached for recruitment.
Patients eligible for entry were aged 17–70, with at least
one musculoskeletal injury. Head injuries are known to
aﬀect psychological perception of injuries and so those
with signiﬁcant head injuries (unconscious more than 15
minutes, Glasgow Coma Scale less than 13) were excluded.
Patients with fragility fractures were also excluded. Patients
were recruited within 48 hours of their injury, by means
of discussion, information sheet, and informed consent
record. They were asked to complete the General health
Questionnaire (GHQ) at initial presentation, and gave an
early morning sample of blood. Demographic data related
to their injuries and backgrounds were collected, including
injury severity score (ISS) [26], the new injury severity
score (NISS) [27, 28], the revised trauma score (RTS)
[29], and the TRISS methodology score [30]. The study
had the full approval of the local research ethics commit-
tee.
The GHQ is a validated and robust self-administered
screening measure to detect psychiatric disorders in commu-
nity and nonpsychiatric clinical settings [31, 32]. It is a 28-
item questionnaire, producing a total score (a higher score
representing more severe psychiatric disturbance). The total
score further allows a threshold to be applied that deﬁnes
“caseness”—the situation where it is likely that clinical
examination by a mental health specialist would identify
a genuine psychiatric condition. This does not deﬁne that
the patient has a speciﬁc psychiatric diagnosis (this would
require a two-stage approach), but it is a useful tool for
identifying patients who would be so deﬁned. The threshold
for this caseness deﬁnition is generally taken as a score of 5
andabove(outof28)[31].Inaposttraumaticsetting,thereis
often extensive symptom overlap, and the GHQ allows us to
identifythosepatientswithapsychiatricdisturbancewithout
narrowing the focus to one or more speciﬁc diagnoses (e.g.,
PTSD).
Blood was drawn between 0730 and 0830 for each
patient, in order to reduce the potential confounding
eﬀect of circadian rhythmns in production of biomark-
ers under investigation. Sampling used a tourniquet and
vacutainer technique, taking 20mL in two-clotting vacu-
tainers. The clotted samples were centrifuged at 2900rpm
for 15 minutes, and the serum carefully transferred to
nonsterile 5mL vials (eppendorfs) using a microtitre pipette
(Gilson). The serum samples were stored at −40◦Cf o r
no more than 24 hours before being transferred to a
−70◦C freezer until required, when they were allowed
to thaw at room temperature. TNF-α, IL-6, and sIL-6r
assays were carried out using solid-phase enzyme-linked
imunosorbant Assay assay (ELISA) kits (Quantikine, R&D
Systems Inc, Minneapolis, Minn, USA, distributed in the
UK by R&D Systems Europe, Abingdon, Oxon, UK). CRP
assays were carried out in the routine microbiology labo-
ratories of Aberdeen Royal Inﬁrmary. Plasma GABA levels
were determined using an LC-MS-MS chromatography
method.
Patients were followed up in line with standard clinical
care for their injuries. They were asked to repeat the GHQ at
two- and six-month follow-up.
StatisticalanalysiswasundertakenontheStatisticalPack-
age for Social Sciences (SPSS v 16.0, SPSS Inc, Chicago, Ill,
USA). Diﬀerences between GHQ caseness rates at diﬀerent
follow-up times were analysed using the Wilcoxon signed-
ranks test. Normality of biomechanical data was tested using
the Shapiro-Wilks test. Relationships between biochemical
markers, categorical demographic data, and GHQ caseness
were explored with the independent samples t-test, and
those between the individual biochemical markers and GHQ
scores with Pearson correlation testing. Logistic regression
analysis was used to assess the predictive value of the
biochemical markers on GHQ caseness.
3. RESULTS
During the course of the study, 84 patients were successfully
recruited to the metabolic markers group. Their mean age
was 36 years (range 16–68 years), and 75% were men. Fifty
percent were married or cohabiting, while 45% were single,
and 5% separated from partners. Alcohol consumption
was greater than 20 units per week in 14 (17%), while
35% were smokers. Only one patient admitted the use of
controlled substances, and eight had previous psychiatric
services contact.
The mechanism of injury is summarised in Table 1.T h e
patients had sustained a variety of musculoskeletal injuries,
predominantly fractures, and 28 (35.5%) had multiple
injuries. The modal ISS was nine (range 4–25), modal
NISS was also nine (range 4–41). The mode RTS was 7.84
(range 6.38–7.84), and the modal TRISS survival probability
was 99.40% (range 93.30–99.80%). Injuries were managed
surgically in 89% of cases. Follow-up for the group was 68
(81%) at two months and 62 (74%) at six months.Alasdair George Sutherland et al. 3
Table 1: Mechanism of injury (RTA = road traﬃc accident).
Mechanism No. patients (%)
Fall Total 29 (36)
Low energy 18 (22)
From height 11 (14)
Work including machinery 8 (10)
RTA Total 35 (41)
Driver 12 (14)
Passenger 7 (8)
Motorcycle 11 (13)
Cyclist 2 (2)
Pedestrian 3 (4)
Sport 11 (14)
Assault 1( 1 )
ThemeanGHQscoreatinitialpresentationwas1.31(out
of 28), rising at two months to 6.10, falling by six months
to 3.39 (diﬀerences between follow up and baseline levels
P<. 001, Wilcoxon signed-ranks test). The initial caseness
level was 11%, rising to 39% at two months, and falling back
partially to 18% by six months (diﬀerences between follow-
up and baseline P<. 02, Wilcoxon signed-ranks test).
The mean standard deviation and the range for each
of the biological markers are shown in Table 2. With the
exception of GABA, each has a wide range. The measured
quantity of each of the biological variables was normally
distributed (Shapiro-Wilks test, P<. 01). There were
no correlations between levels of biological markers and
demographic data including age (by age bands), sex, and
type of injury (independent samples t-test, P>. 05) and
ISS score, NISS score, TRISS, and RTS (Pearson’s correlation,
P>. 05). There were no correlations between GABA level
and the levels of other biomarkers under investigation (IL-6,
sIL6r, TNF-α, and CRP) (Pearson’s correlation, P>. 05).
The levels of GABA, IL-6, sIL6r, TNF-α, and CRP did
not correlate with GHQ total score at initial assessment and
two- or six-month follow up (Pearson’s correlation, P>. 05).
Similarly, the mean levels were not signiﬁcantly diﬀerent
between cases and noncases (GHQ cut-oﬀ score ﬁve and
above)(independentsamplest-test,P>. 05).Logisticregres-
sion analysis revealed that none of the biochemical markers
had any predictive value for GHQ caseness (P>. 10).
4. DISCUSSION
The relationship between markers of HPAA function after
musculoskeletal injury and the risk of developing posttrau-
matic psychological problems is complex, and we have not
been able to identify a simple predictive test from our data.
Posttraumatic psychopathology is an important compli-
cation of musculoskeletal trauma of the sort that presents
every day to orthopaedic trauma surgeons. It is associated
with a signiﬁcant delay in functional recovery, and it is clear
that genuinely holistic care of the injured patient should
include the psychological state. Psychological interventions
Table 2: Biological markers levels.
Metabolic markers Initial (n = 84)
Mean (SD) Range
GABA (nmoL·L
−1) 0.55 (0.243) 0.28–2.01
CRP (mg·L
−1) 44 (49.81) 0–251.20
IL-6 (pg·mL
−1) 83.75 (386.22) 0–3393.08
sIL-6r (pg·mL
−1) 36361 (8418) 14587–66958
TNF-α (pg·mL
−1) 27.37 (95.28) 0–754.01
for PTP, including PTSD, are established, but are often
limited in resource, and so should be targeted at those most
in need.
We have previously reported on the relationship between
psychological and physiological state after trauma [4], but
have focused on incident-speciﬁc data in the prediction of
at-risk status in our patients [9]. The recent suggestion
that GABA may be useful in PTSD prediction in the
short term [11] prompted our examination of GABA and
proinﬂammatory markers of the metabolic response to
trauma and their relationship to subsequent development of
PTP.
Cortisol or ACTH assays are the most direct measures
of HPA function and have been used to predict PTSD
symnptomatology [33], but require complex methodology,
particularly in speciﬁc timing of testing due to the eﬀects
of complex circadian rhythmns. Function of HPA and
proinﬂammatory markers of trauma are enmeshed and
complex, but it has been suggested that proinﬂammatory
cytokine levels can provide a physiological correlation with
HPA function [17]. It is not possible to identify a single
marker of the inﬂammatory response to trauma. Each of
the three cytokines (IL-6, sIL-6r, and TNF-α) that we have
tested as well as CRP have been used in various studies of the
response to physical trauma, including surgery [15, 34–48].
A focus upon PTSD as the sole psychiatric consequence
of trauma is, in our view, too narrow. There is extensive
symptom overlap in posttraumatic conditions, and while
some patients will exhibit frank PTSD, others may not
reach the diagnostic threshold while still suﬀering signif-
icant distress and dysfunction in their everyday life. For
this reason, we have preferred to consider posttraumatic
psychopathology (PTP) as representing the full spectrum
of pathological reactions to injury, including associated
depression or anxiety. This has led us to use GHQ as
a screening tool for general psychiatric symptomatology,
rather than focussing on a single diagnosis; we believe that
this approach more truly reﬂects, in a practical way, the
experience of our patients rather than in a research-driven
enquiry.
Our data suggest no useful prediction of subsequent
PTP by the assessment of HPA axis function, as measured
by GABA, CRP, and proinﬂammatory cytokines. We have
previously demonstrated the importance of the patient’s
perception of the incident, and would suggest that it more
strongly predicts PTP than a snapshot of physiological
markers [9].4 Mediators of Inﬂammation
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